On Monday, Omega Healthcare Investors Inc (NYSE:OHI)’s shares inclined 0.87% to $36.02.
Omega Healthcare Investors, Inc. (OHI) declared that the Company’s Board of Directors declared a common stock dividend of $0.55 per share. The common stock dividend is payable Monday, August 17, 2015 to common stockholders of record as of the close of business on Friday, July 31, 2015.
Tidewater Inc. provides offshore service vessels and marine support services through the operation of a fleet of marine service vessels to the offshore energy industry worldwide. The company operates in Americas, Asia/Pacific, Middle East/North Africa, and Sub-Saharan Africa/Europe segments.
Endeavour Silver Corp (NYSE:EXK)’s shares dropped -0.69% to $1.43.
Endeavour Silver Corp. (EXK) posted steady silver production results in the Second Quarter, 2015 from the Company’s three operating silver mines in Mexico: the Guanaceví mine in Durango State and the Bolañitos and El Cubo mines in Guanajuato State.
Silver production in the Second Quarter, 2015 was on plan for the year at 1,769,741 ounces (oz) and gold production was 13,047 oz, slightly below plan.
Production Highlights for Second Quarter, 2015 (Contrast to Second Quarter, 2014)
- Silver production raised 6% to 1,769,741 oz
- Gold production reduced 14% to 13,047 oz
- Silver equivalent production reduced 2% to 2.7 million oz (at a 70:1 silver: gold ratio)
- Silver oz sold up 8% to 1,912,595 oz
- Gold oz sold down 6% to 13,797 oz
- Bullion inventory at quarter-end comprised of 187,954 oz silver and 399 oz gold
- Concentrate inventory at quarter-end comprised of 43,441 oz silver and 567 oz gold
Endeavour Silver Corp., a Canadian mineral company, engages in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. It produces silver-gold from its underground mines. The company primarily holds interests in the Guanacevi mine in the Durango state; and the Bolañitos and El Cubo mines in the Guanajuato state of Mexico.
At the end of Monday’s trade, Ross Stores, Inc. (NASDAQ:ROST)‘s shares surged 1.07% to $52.83.
Ross Stores declared the opening of 19 Ross Dress for Less® (“Ross”) and 8 dd’s DISCOUNTS® stores across 15 different states in July. These new locations are part of the off-price retailer’s 2015 expansion plans to add a total of about 90 stores during the year, counting 70 Ross and 20 dd’s DISCOUNTS.
Ross Stores, Inc. is an S&P 500, Fortune 500 and Nasdaq 100 (ROST) company headquartered in Dublin, California, with fiscal 2014 revenues of $11.0 billion. Presently, the Company operates Ross Dress for Less® (“Ross”), the largest off-price apparel and home fashion chain in the United States with 1,260 locations in 33 states, the District of Columbia and Guam. Ross offers first-quality, in-season, name brand and designer apparel, accessories, footwear and home fashions for the entire family at savings of 20% to 60% off department and specialty store regular prices every day. The Company also presently operates 165 dd’s DISCOUNTS® in 15 states that feature a more moderately-priced assortment of first-quality, in-season, name brand apparel, accessories, footwear and home fashions for the entire family at savings of 20% to 70% off moderate department and discount store regular prices every day. Additional information is accessible at www.rossstores.com.
Ross Stores, Inc., together with its auxiliaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dds DISCOUNTS brand names in the United States. It primarily offers apparel, accessories, footwear, and home fashions.
Organovo Holdings Inc (NYSEMKT:ONVO), ended its Monday’s trading session with -0.77% loss, and closed at $3.85.
Organovo Holdings, Inc. (ONVO “), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, declared recently that the July 8th presentation given by President and CEO Keith Murphy at Cantor Fitzgerald Inaugural Healthcare Conference is now accessible via a webcast replay for the next 90 days.
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
